Internal Medicine, Endocrinology, Diabetes, & Metabolism · Sumter, SC
NPI
1437241262
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
635 W Wesmark Blvd
Sumter, SC, 29150
Phone (803) 469-7500
Groups this clinician bills Medicare through
Medicare paid, 2024
$383K
12,160 services
Medicare patients, 2024
572
Average age 74
Drug cost, 2024
$2.7M
2,630 prescriptions
Company payments, 2025
$400
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Usah Lilavivat was code J0897 (injection, denosumab, 1 mg), 3,120 times for 35 patients. In total Usah Lilavivat billed 12,160 services in 100 codes, and Medicare paid $383K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-06-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,120 | 35 | $17.80 | $56K |
| 36415 Venipuncture Blood Collection | Office | 755 | 456 | $7.93 | $5,984 |
| 80053 Clinical Chemistry | Office | 562 | 354 | $10.28 | $5,779 |
| 83036 Blood Count | Office | 464 | 321 | $9.45 | $4,384 |
| 99214 Office E&M - Established | Office | 450 | 375 | $86.55 | $39K |
| 85025 Blood Count | Office | 446 | 242 | $7.59 | $3,384 |
| 84443 Clinical Chemistry | Office | 438 | 271 | $16.38 | $7,175 |
| 84439 Clinical Chemistry | Office | 428 | 266 | $8.81 | $3,769 |
| 84481 Clinical Chemistry | Office | 418 | 264 | $16.54 | $6,912 |
| 99215 Office E&M - Established | Office | 320 | 182 | $139.45 | $45K |
| 80061 Clinical Chemistry | Office | 298 | 199 | $12.63 | $3,764 |
| 82306 Clinical Chemistry | Office | 256 | 174 | $29.01 | $7,427 |
| 83970 Clinical Chemistry | Office | 228 | 161 | $40.44 | $9,220 |
| 82570 Clinical Chemistry | Office | 200 | 141 | $5.05 | $1,009 |
| 99211 Office E&M - Established | Office | 185 | 80 | $17.02 | $3,150 |
By year: 2022 $650K for 45,398 services; 2023 $483K for 29,685 services; 2024 $383K for 12,160 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 755 | 456 | $7.93 | $5,984 |
| 80053 Clinical Chemistry | 562 | 354 | $10.28 | $5,779 |
| 83036 Blood Count | 464 | 321 | $9.45 | $4,384 |
| 85025 Blood Count | 446 | 242 | $7.59 | $3,384 |
| 84443 Clinical Chemistry | 438 | 271 | $16.38 | $7,175 |
| 84439 Clinical Chemistry | 428 | 266 | $8.81 | $3,769 |
| 84481 Clinical Chemistry | 418 | 264 | $16.54 | $6,912 |
| 80061 Clinical Chemistry | 298 | 199 | $12.63 | $3,764 |
| 82306 Clinical Chemistry | 256 | 174 | $29.01 | $7,427 |
| 83970 Clinical Chemistry | 228 | 161 | $40.44 | $9,220 |
Medicare prescription drug claims, 2024
In 2024, the drug Usah Lilavivat prescribed most often to Medicare patients was Levothyroxine Sodium, with 280 prescriptions and refills. In total Usah Lilavivat wrote 2,630 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 280 | 687 | 79 | $2,861 |
| Mounjaro Tirzepatide | 156 | 169 | 24 | $176K |
| Jardiance Empagliflozin | 112 | 185 | 26 | $105K |
| Ozempic Semaglutide | 100 | 133 | 24 | $127K |
| Methimazole Generic | 94 | 205 | 27 | $1,374 |
| Amlodipine Besylate Generic | 82 | 211 | 23 | $637 |
| Synthroid Levothyroxine Sodium | 76 | 135 | 13 | $4,975 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 71 | 142 | 25 | $8,224 |
| Metformin Hcl Generic | 68 | 188 | 27 | $574 |
| Korlym Mifepristone | 53 | 53 | Under 11 | $1.9M |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 51 | 67 | Under 11 | $38K |
| Humalog Insulin Lispro | 50 | 88 | Under 11 | $12K |
| Metformin Hcl Er Metformin Hcl | 42 | 109 | 18 | $717 |
| Rosuvastatin Calcium Generic | 42 | 114 | 14 | $704 |
| Farxiga Dapagliflozin Propanediol | 40 | 46 | Under 11 | $26K |
Brand drugs: 1,158 claims; generic drugs: 1,331 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Usah Lilavivat $400 ($400 in general payments such as food, travel and fees) from 6 companies. The largest payer was Amgen Inc. with $98.12.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.